Tip:
Highlight text to annotate it
X
According to a new PwC US report, "Dollar drought," that includes data from the PricewaterhouseCoopers
LLP/National Venture Capital Association MoneyTree™ Report, based on data from Thomson Reuters,
Venture capital funding in the Life Sciences sector, which includes the Biotechnology and
Medical Device industries, decreased 39% in dollars and 22% in number of deals during
the second quarter of 2012 from the same quarter of last year.
During the second quarter, Biotechnology and medical devices each accounted for 10 percent
of total funding.
For the complete article, please go to Big4.com